chimeric antigen receptor T-cell therapy

Bispecific T-Cell Engagers Show Potential for Resetting the Immune System in Refractory Autoimmune Disease Bispecific T-cell engagers (BiTEs) are emerging as a promising strategy to achieve an “immune reset” in …

## Promising Advances in Lymphoma Treatment: Key Takeaways from ASCO 2025 Recent presentations at the American Society of Clinical Oncology (ASCO) 2025 conference have highlighted important progress in the fight …